FDA warn Chantix could affect patients' alcohol tolerance Medical News Today

March 10, 2015 4:29 PM

22 0

Pfizer, the manufacturer of Chantix (varenicline), submitted a case series to the Food and Drug Administration (FDA) which was reviewed alongside reported cases of patients experiencing adverse reactions to the drug from the FDA Adverse Event Reporting System (FAERS) database.

Chantix is a widely-used smoking cessation medicine approved for use by the FDA in 2006. The FDA state that in 2013, an estimated 1.2 million patients received a dispensed prescription for Chantix from outpatient retail pharmacies in the US.

Read more

To category page